Abstract:OBJECTIVE:To explore the relationships between the expressions of estrogen receptor (ER), progestin receptor (PR), phosphatase and tension homology deleted on chromosome ten (PTEN), p53, Ki-67 and the clinicopathologic features and prognosis in endometrial carcinoma.METHODS:The data of clinical characteristics, pathological types, histological grades, follow-ups and the expressions of molecular markers detected by immunohistochemistry, and collected from 200 patients with primary endometrial carcinoma, were analyzed.RESULTS:(1) In the cases of endometrial carcinoma, the expression rates of ER, PR, PTEN, p53 were 86.5%, 85.5%, 82.1%, and 49.2%, respectively. The expression level of Ki-67 in the tumor tissues was 46.9% ± 24.7%. (2) A negative correlation was observed between the gravidity and the expression of PR (r=-0.191, P=0.007). On the other hand, age and parturition time were in positive correlation with the expression of p53 (r=0.184, P=0.041; r=0.255, P=0.004). (3) The expression rates of ER, PR and p53 in the endometrioid carcinoma exhibited significant differences comparing with other types (P<0.01). (4) A negative correlation was found between the expression of ER and the FIGO staging (r=-0.176, P=0.013). The positive rate of ER in the cases with Stage I was higher than that in cases with Stage II and above (P=0.015). (5) A negative correlation was found between the histological grade and the expressions of ER and PR (r=-0.217, P=0.002; r= -0.317, P=0.000), however, a positive correlation was detected between the grade with the expressions of p53 and Ki-67 (r=0.327, P=0.000; r=0.465, P=0.000). Compared with the grade 3 tumors, the other grades exhibited significant different expression levels of ER, PR, p53, and Ki-67 (P<0.01). (6) A negative correlation was observed between the depth of myometrial invasion and the positive rate of ER (r=-0.142, P=0.047). There were statistically significant different expression rates of ER and PR between the cases whether the cancer invaded the deep myometrium or not (P<0.05). (7) Multivariate survival analysis showed that patients with PR (+) had longer overall survival than those with PR (-) (P=0.011).CONCLUSION:The immunohistochemical study of endometrium samples obtained from dilatation and curettage of uterine will be beneficial to the understanding of the clinicopathologic features of the endometrial carcinoma before the operation. The value of estimating the prognosis using the expressions of ER, PTEN, p53 and Ki-67 was negative, except for the expression of PR.

Progesterone Receptor Status of Epithelial Cells as a Predictive Marker for Postoperative Recurrence of Endometriosis

Upregulation of H-Tert and Ki-67 in Ectopic Endometrium is Associated with Recurrence of Endometriosis

The Clinical Picture and Fecundity of Primary and Recurrent Ovarian Endometriosis with Family History: A Retrospective Analysis

Progesterone receptor B over progesterone receptor A prevents recurrence in bilateral endometriomas

Immunoreactivity of Progesterone Receptor Isoform B and Nuclear Factor Kappa-B As Biomarkers for Recurrence of Ovarian Endometriomas

Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma

Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer

Expressions of Estrogen and Progesterone Receptors and its Prognosis Value in epithelial ovarian cancer

The Prognostic Significance Of Estrogen And Progesterone Receptors In Grade I And Ii Endometrioid Endometrial Adenocarcinoma: Hormone Receptors In Risk Stratification

Status and related factors of postoperative recurrence of ovarian endometriosis: a cross-sectional study of 874 cases

Expression of cellular adherent and invasive molecules in recurrent ovarian endometriosis

Risk factors for postoperative recurrence of ovarian endometriosis: long-term follow-up of 358 women

Cyclooxygenase-2 Overexpression in Ovarian Endometriomas is Associated with Higher Risk of Recurrence.

Estrogen Receptor- And Progesterone Receptor-Positive Thresholds in Predicting the Recurrence of Early Low-Risk Endometrial Cancer

Expression of Endometrial Receptivity Markers throughout the Menstrual Cycle in Women with and without Uterine Adenomyosis

Predicting disease recurrence in patients with endometriosis: an observational study

Patterns of and Risk Factors for Recurrence in Women with Ovarian Endometriomas

Does Programmed Cell Death 1 Ligand (Pd-L1) Expression Predict Recurrence in Women With Endometrioma?

Impact of estrogen and progesterone receptor expression on the incidence of endometrial polyps

Analysis of Factors Associated With Recurrence of Early-Stage Endometrial Carcinoma and Atypical Endometrial Hyperplasia in Infertile Women After In Vitro Fertilization Treatment

Relationships Between the Molecular Biomarkers and the Clinicopathologic Features and Prognosis in Endometrial Carcinoma